Does leptin contribute to obesity hypertension?

John E. Hall, Eugene W M Shek, Michael W Brands

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The discovery of leptin and its multiple biologic actions, including sympathetic nervous system (SNS) activation, has provided a possible link between obesity and hypertension. Short-term leptin administration directly into the brain stimulates sympathetic activity, and long-term leptin infusion, at rates that mimic plasma concentrations found in obesity, increases arterial pressure via adrenergic activation in nonobese rodents. Short-term studies suggest that the sympathetic effects of leptin may depend on interactions with other neurochemical pathways in the hypothalamus, such as melanocortin receptors. However, it is still unclear whether there is resistance to the long-term SNS and blood pressure effects of leptin in obesity. Results from clinical trials using long-term leptin administration in humans in an attempt to reduce body weight should help to answer some of these questions.

Original languageEnglish (US)
Pages (from-to)225-229
Number of pages5
JournalCurrent Opinion in Endocrinology and Diabetes
Volume6
Issue number3
DOIs
StatePublished - Jun 23 1999
Externally publishedYes

Fingerprint

Leptin
Obesity
Hypertension
Sympathetic Nervous System
Melanocortin Receptors
Adrenergic Agents
Hypothalamus
Rodentia
Arterial Pressure
Body Weight
Clinical Trials
Blood Pressure
Brain

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Does leptin contribute to obesity hypertension? / Hall, John E.; Shek, Eugene W M; Brands, Michael W.

In: Current Opinion in Endocrinology and Diabetes, Vol. 6, No. 3, 23.06.1999, p. 225-229.

Research output: Contribution to journalArticle

Hall, John E. ; Shek, Eugene W M ; Brands, Michael W. / Does leptin contribute to obesity hypertension?. In: Current Opinion in Endocrinology and Diabetes. 1999 ; Vol. 6, No. 3. pp. 225-229.
@article{dc7d5bb85d6449f6b713aa2a59c797ee,
title = "Does leptin contribute to obesity hypertension?",
abstract = "The discovery of leptin and its multiple biologic actions, including sympathetic nervous system (SNS) activation, has provided a possible link between obesity and hypertension. Short-term leptin administration directly into the brain stimulates sympathetic activity, and long-term leptin infusion, at rates that mimic plasma concentrations found in obesity, increases arterial pressure via adrenergic activation in nonobese rodents. Short-term studies suggest that the sympathetic effects of leptin may depend on interactions with other neurochemical pathways in the hypothalamus, such as melanocortin receptors. However, it is still unclear whether there is resistance to the long-term SNS and blood pressure effects of leptin in obesity. Results from clinical trials using long-term leptin administration in humans in an attempt to reduce body weight should help to answer some of these questions.",
author = "Hall, {John E.} and Shek, {Eugene W M} and Brands, {Michael W}",
year = "1999",
month = "6",
day = "23",
doi = "10.1097/00060793-199906000-00010",
language = "English (US)",
volume = "6",
pages = "225--229",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Does leptin contribute to obesity hypertension?

AU - Hall, John E.

AU - Shek, Eugene W M

AU - Brands, Michael W

PY - 1999/6/23

Y1 - 1999/6/23

N2 - The discovery of leptin and its multiple biologic actions, including sympathetic nervous system (SNS) activation, has provided a possible link between obesity and hypertension. Short-term leptin administration directly into the brain stimulates sympathetic activity, and long-term leptin infusion, at rates that mimic plasma concentrations found in obesity, increases arterial pressure via adrenergic activation in nonobese rodents. Short-term studies suggest that the sympathetic effects of leptin may depend on interactions with other neurochemical pathways in the hypothalamus, such as melanocortin receptors. However, it is still unclear whether there is resistance to the long-term SNS and blood pressure effects of leptin in obesity. Results from clinical trials using long-term leptin administration in humans in an attempt to reduce body weight should help to answer some of these questions.

AB - The discovery of leptin and its multiple biologic actions, including sympathetic nervous system (SNS) activation, has provided a possible link between obesity and hypertension. Short-term leptin administration directly into the brain stimulates sympathetic activity, and long-term leptin infusion, at rates that mimic plasma concentrations found in obesity, increases arterial pressure via adrenergic activation in nonobese rodents. Short-term studies suggest that the sympathetic effects of leptin may depend on interactions with other neurochemical pathways in the hypothalamus, such as melanocortin receptors. However, it is still unclear whether there is resistance to the long-term SNS and blood pressure effects of leptin in obesity. Results from clinical trials using long-term leptin administration in humans in an attempt to reduce body weight should help to answer some of these questions.

UR - http://www.scopus.com/inward/record.url?scp=0033039481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033039481&partnerID=8YFLogxK

U2 - 10.1097/00060793-199906000-00010

DO - 10.1097/00060793-199906000-00010

M3 - Article

AN - SCOPUS:0033039481

VL - 6

SP - 225

EP - 229

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 3

ER -